Avisa Diagnostics Inc.
FOGCFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$97176
P/E Ratio—
52W High$0.00001
52W Low$0.000001
Avisa Diagnostics Inc. (FOGCF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FOGCF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2020-12 | 2019-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.28M | $0.86M |
| Cost of Revenue | $0.15M | $2.80M |
| Gross Profit | $0.13M | ($1.94M) |
| Gross Margin %(computed) | 46.53% | -226.57% |
| Operating Expenses | ||
| R&D Expenses | $0.00M | $0.00M |
| G&A Expenses | $0.86M | $0.00M |
| Total Operating Expenses | $1.03M | $0.79M |
| Operating Income | ($0.90M) | ($2.73M) |
| Operating Margin %(computed) | -324.17% | -318.28% |
| Interest Income | $0.00M | $0.00M |
| Interest Expense | $0.02M | $0.00M |
| Income Before Tax | ($0.72M) | ($4.23M) |
| Income Tax Expense | $0.00M | ($0.00M) |
| Net Income | ($0.72M) | ($4.13M) |
| Net Margin %(computed) | -257.63% | -481.60% |
| Per Share & EBITDA | ||
| EPS (Basic) | $-0.14 | $-0.86 |
| Wtd Avg Shares | 5.22M | 4.92M |
| EBITDA | ($0.68M) | ($3.24M) |
| EBITDA Margin %(computed) | -244.26% | -377.68% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Avisa Diagnostics Inc. data
About Avisa Diagnostics Inc. (FOGCF) Income Statement
Avisa Diagnostics Inc. (FOGCF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2020, FOGCF reported revenue of $0.00B, gross profit of $0.00B (gross margin 46.53%), and net income of ($0.00B) — a net profit margin of -257.63%.
Frequently asked questions
FOGCF · 4 questionsAvisa Diagnostics Inc. (FOGCF) reported revenue of $0.00B for 2020, down 67.6% year-over-year.
FOGCF revenueFOGCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09